NetworkNewsBreaks

ThursdayMar 27, 2025 10:00 am

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Option Agreement to Acquire Italian Biotech Pincell

Scinai Immunotherapeutics (NASDAQ: SCNI), announced it has signed a binding option agreement to acquire Pincell srl, an Italian biotech developing PC111, a first-in-class antibody targeting severe skin blistering disorders. In tandem, Scinai's Polish subsidiary submitted a €12 million non-dilutive grant application under the EU’s FENG program to fund the next development phase of PC111. The agreement positions Scinai to advance treatments for high-mortality conditions like pemphigus and Stevens-Johnson Syndrome without immunosuppression, with Pincell's leadership expected to integrate into Scinai’s expanding European operations. To view the full press release, visit https://nnw.fm/RlLeU About Scinai Immunotherapeutics Ltd. Scinai is a biopharmaceutical company with…

Continue Reading

ThursdayMar 27, 2025 9:25 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Targets AI and Robotics Expansion with Pending Acquisitions

Nightfood Holdings (OTCQB: NGTF) announced it is nearing the completion of two key acquisitions—Carryout Supplies (S W C Group) and Skytech Automated Solutions—as part of its strategy to lead innovation at the intersection of AI, robotics and hospitality. The acquisition of Carryout Supplies is expected to close imminently, followed closely by the acquisition of Skytech, which recently expanded its AI-powered Laundry Helper robot to a second location. These moves mark a significant milestone in Nightfood’s evolution from a specialty food company to a hospitality tech innovator, with further strategic expansion under active consideration. To view the full press release, visit…

Continue Reading

WednesdayMar 26, 2025 12:07 pm

NetworkNewsBreaks – Pinterest Inc. (NYSE: PINS) Gains Hedge Fund Interest as Affordable Stock Option 

Pinterest (NYSE:PINS) has garnered attention from hedge funds, ranking 10th on Insider Monkey's list of the 14 best affordable stocks to buy. As of the fourth quarter of 2024, 73 hedge funds held positions in the company. The stock was priced at $32.42 as of March 22, 2025. ​   As of 10:25 AM EDT on March 26, 2025, Pinterest's stock is trading at $33.41, reflecting a decrease of $1.22 (3.52%) from the previous close.​  To view the full article, visit https://nnw.fm/IMMtL  About Pinterest, Inc.  Pinterest, Inc. is a visual discovery platform that enables users to find inspiration for various projects…

Continue Reading

WednesdayMar 26, 2025 12:01 pm

NetworkNewsBreaks – Trump Media & Technology Group Corp. (NASDAQ: DJT) Shares Surge Following ETF Partnership with Crypto.com 

Trump Media & Technology Group (NASDAQ: DJT) the parent company of Truth Social, experienced a notable stock increase after announcing a partnership with Crypto.com to launch a series of exchange-traded funds (ETFs). These ETFs will focus on digital assets and securities emphasizing a "Made in America" theme, encompassing industries such as energy. Crypto.com will provide the backend technology and supply the cryptocurrencies for the ETFs, which are expected to include a unique basket of cryptocurrencies like Bitcoin and Cronos. The collaboration aims to offer investors options that align with their principles and support U.S. companies focused on their core businesses.…

Continue Reading

WednesdayMar 26, 2025 11:22 am

NetworkNewsBreaks – Microsoft Corp. (NASDAQ: MSFT) Offers Cost-Saving Solutions with Lifetime Office Licenses 

Microsoft (NASDAQ: MSFT) Microsoft Corporation (NASDAQ: MSFT) is providing businesses with an opportunity to reduce software expenses by offering lifetime licenses for Microsoft Office 2021. This initiative allows companies to avoid the recurring annual fees associated with Microsoft 365 subscriptions, which can amount to approximately $144 per user. By opting for a one-time purchase of $49.97 per license, businesses gain perpetual access to essential productivity applications such as Word, Excel, Outlook, and Teams. This approach not only results in significant cost savings but also streamlines operations by eliminating the need for annual subscription renewals. ​   As of 10:10 AM EDT…

Continue Reading

WednesdayMar 26, 2025 11:10 am

NetworkNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Stock Surges Amid AI Expansion Talks

Meta Platforms (NASDAQ: META) experienced a notable stock increase, closing up 3.9% on Monday, March 24, 2025. This surge follows reports of Meta's discussions with India's Reliance Industries to host Meta's AI models in a forthcoming data center in Jamnagar, Gujarat, projected to be the world's largest. The potential collaboration underscores Meta's commitment to expanding its artificial intelligence footprint in the rapidly growing Indian market. Additionally, Meta reported a 22% revenue increase in 2024, reaching $164.5 billion, reflecting robust growth in its core social media business. ​ As of 10:28 AM EDT on March 26, 2025, Meta's stock is trading…

Continue Reading

WednesdayMar 26, 2025 11:00 am

NetworkNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) Reports Strong 2024 Revenue Growth Driven by Core Services

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) reported a 14% increase in revenue for 2024, reaching $350 billion. The growth was primarily driven by its core services, with Google Search generating $198.1 billion (56.6% of total revenue) and YouTube Ads contributing $36.1 billion (10.3%). Google Cloud also saw significant growth, bringing in $43.2 billion (12.4%). The U.S. market accounted for approximately half of Alphabet's annual sales. ​ As of 10:33 AM EDT on March 26, 2025, Alphabet's stock is trading at $170.28, reflecting a decrease of $2.51 (1.45%) from the previous close.​ To view the full article, visit https://nnw.fm/UM5ZY About Alphabet Inc.…

Continue Reading

WednesdayMar 26, 2025 10:45 am

NetworkNewsBreaks – Amazon.com Inc. (NASDAQ: AMZN) Stock Rebounds Amid Positive AI Outlook Post-Nvidia Conference

Amazon.com (NASDAQ: AMZN) experienced a stock uptick following analyst optimism regarding its artificial intelligence (AI) prospects after Nvidia's recent GTC conference. Monness Crespi Hardt analyst Brian White highlighted Amazon Web Services' (AWS) potential to benefit from the growing generative AI sector, reiterating a buy rating with a price target of $215. Despite a seven-week decline in Amazon's stock amid a broader market downturn, analysts remain positive about the company's long-term growth, particularly in AI. ​As of 10:09 AM EDT on March 26, 2025, Amazon's stock is trading at $202.94, reflecting a decrease of $2.77 (1.35%) from the previous close.​ To…

Continue Reading

WednesdayMar 26, 2025 10:35 am

NetworkNewsBreaks – Tesla Inc. (NASDAQ: TSLA) Stock Rises for Fifth Consecutive Session Amid Analyst Optimism

Tesla (NASDAQ: TSLA) has achieved its fifth consecutive day of stock gains, closing at $288.14 on Tuesday, March 25, 2025. This 3.5% increase brings the stock up 28% over the past five days, reversing a two-month decline. The rally comes despite reports of falling sales in the European Union for the second consecutive month. Analysts attribute the surge to CEO Elon Musk's encouragement for employees to retain their shares and confidence in Tesla's self-driving and robotics technology. Key resistance levels to monitor include $300, $385, and $680, while support levels are identified at $217 and $155. ​ As of 10:13…

Continue Reading

WednesdayMar 26, 2025 10:32 am

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Reports Encouraging Progress in Brain Cancer Trial with City of Hope

Calidi Biotherapeutics (NYSE American: CLDI) announced promising early results from a phase 1 clinical trial evaluating its CLD-101 investigational agent, a neural stem cell-based oncolytic virotherapy, in collaboration with City of Hope. The trial, targeting recurrent high-grade glioma, is the first to assess multiple weekly intracerebral doses of CLD-101. Fourteen participants have been treated so far with no safety concerns, and the study is now enrolling patients into the highest dosing cohort. The trial has expanded to Northwestern University and Stanford University, and is supported by a $12 million grant from the California Institute for Regenerative Medicine. Calidi retains licensing…

Continue Reading